November 30, 2016
FTC v. Boehringer Ingelheim Pharmace
Case Number:
16-5356
Court:
Nature of Suit:
Companies
Government Agencies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
January 06, 2023
Ahead Of Privilege Arguments, 4 Kavanaugh Rulings To Know
The U.S. Supreme Court will hear arguments Monday about how to interpret the protection for communications containing both legal and nonlegal topics. But don't expect any overt attempt to convince the court — and particularly Justice Brett Kavanaugh — that a competing "one significant purpose" standard is flat wrong. Here, Law360 Pulse breaks down four significant Justice Kavanaugh decisions dealing with the issue.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login